المؤلفون: Mo Z, Hu MG, Yu F, Shao LJ, Fan KX, Jiao SC

المصدر: OncoTargets and Therapy, Vol Volume 11, Pp 1215-1222 (2018)

مصطلحات موضوعية: Leukemia-related protein 16, pancreatic cancer, proliferation, metastasis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/leukemia-related-protein-16-lrp16-promotes-tumor-growth-and-metastasis-peer-reviewed-article-OTT; https://doaj.org/toc/1178-6930

URL الوصول: https://doaj.org/article/8563cf0391f64210a4002ee507fe7026

المؤلفون: Jia YC, Zang AM, Jiao SC, Chen SM, Yan F

المصدر: OncoTargets and Therapy, Vol 2016, Iss Issue 1, Pp 1715-1719 (2016)

مصطلحات موضوعية: IL-18, polymorphism, NSCLC, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/the-interleukin-18-gene-promoter--607-ac-polymorphism-contributes-to-n-peer-reviewed-article-OTT; https://doaj.org/toc/1178-6930

URL الوصول: https://doaj.org/article/03bb00e515f5414c92c4a1766b83bc0e

المؤلفون: Peng L, Song ZG, Jiao SC

المصدر: OncoTargets and Therapy, Vol 2015, Iss default, Pp 905-910 (2015)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.dovepress.com/comparison-of-uncommon-egfr-exon-21-l858r-compound-mutations-with-sing-peer-reviewed-article-OTT; https://doaj.org/toc/1178-6930

URL الوصول: https://doaj.org/article/b4e29403a2604588b07213326c452b92

المؤلفون: Zhang Gq, Yan X, Jianli Wang, Guan Y, Jiao Sc

المصدر: Cancer Gene Therapy

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Colorectal cancer, Kaplan-Meier Estimate, medicine.disease_cause, Metastasis, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Carcinoma, Non-Small-Cell Lung, Internal medicine, Pancreatic cancer, Biomarkers, Tumor, Tumor Microenvironment, medicine, Carcinoma, Humans, Immunologic Factors, Neoplasm Metastasis, Lung cancer, Molecular Biology, Neoplasm Staging, Proportional Hazards Models, business.industry, Cancer, FOXP3, Prognosis, medicine.disease, Immunohistochemistry, 030104 developmental biology, 030220 oncology & carcinogenesis, Cancer research, Molecular Medicine, Original Article, Carcinogenesis, business, Biomarkers, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdf4aa1abbdcc672a73eb3a147ce528a
https://doi.org/10.1038/cgt.2016.40

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Sun SJ; Department of Medical Oncology, The Fifth Medical Center of General Hospital of Chinese People's Liberation Army, Beijing 100039, China., Han JD; Department of Internal Oncology of Chest, Beijing Cancer Hospital, Beijing 100142, China., Liu W; Peking Cancer Hospital Palliative Care Center, Beijing Cancer Hospital, Beijing 100142, China., Wu ZY; Department of Medical Oncology, The Fifth Medical Center of General Hospital of Chinese People's Liberation Army, Beijing 100039, China., Zhao X; Department of Medical Oncology, The Fifth Medical Center of General Hospital of Chinese People's Liberation Army, Beijing 100039, China., Yan X; Department of Medical Oncology, The Fifth Medical Center of General Hospital of Chinese People's Liberation Army, Beijing 100039, China., Jiao SC; Department of Oncology, The Fifth Medical Center of General Hospital of Chinese People's Liberation Army, Beijing 100039, China. jiaosc@vip.sina.com., Fang J; Department of Internal Oncology of Chest, Beijing Cancer Hospital, Beijing 100142, China.

المصدر: World journal of clinical cases [World J Clin Cases] 2022 Jun 26; Vol. 10 (18), pp. 6069-6081.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 101618806 Publication Model: Print Cited Medium: Print ISSN: 2307-8960 (Print) Linking ISSN: 23078960 NLM ISO Abbreviation: World J Clin Cases Subsets: PubMed not MEDLINE

المؤلفون: Hu GH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Cheng YF; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Zuo YX; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China., Chang YJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Suo P; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Wu J; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China., Jia YP; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China., Lu AD; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China., Li YC; Beijing Yongtai Reike Biotechnology Company Ltd, Beijing, China., Wang Y; Beijing Yongtai Reike Biotechnology Company Ltd, Beijing, China., Jiao SC; Chinese People Liberation Army (PLA) General Hospital, Beijing, China., Zhang LJ; Shenzhen Geno-immune Medical Institute, Shenzhen, China., Zhao XY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Yan CH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Zhang LP; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China., Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China.

المصدر: Frontiers in immunology [Front Immunol] 2022 Jan 07; Vol. 12, pp. 731435. Date of Electronic Publication: 2022 Jan 07 (Print Publication: 2021).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Adoptive Transfer* , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/blood , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/mortality , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy, Adolescent ; Child ; Child, Preschool ; Disease-Free Survival ; Female ; Humans ; Infant ; Male ; Neoplasm, Residual ; Prospective Studies ; Remission Induction ; Survival Rate

المؤلفون: Hu GH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Zhao XY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Zuo YX; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China., Chang YJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Suo P; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Wu J; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China., Jia YP; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China., Lu AD; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China., Li YC; Beijing Yongtai Reike Biotechnology Company Ltd, Beijing, China., Wang Y; Beijing Yongtai Reike Biotechnology Company Ltd, Beijing, China., Jiao SC; Chinese People Liberation Army (PLA) General Hospital, Beijing, China., Zhang LJ; Shenzhen Geno-immune Medical Institute, Shenzhen, China., Kong J; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Yan CH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China., Cheng YF; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China. chengyifei182@sina.com., Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China. ywyw3172@sina.com., Zhang LP; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China., Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China.

المصدر: Leukemia [Leukemia] 2021 Nov; Vol. 35 (11), pp. 3092-3100. Date of Electronic Publication: 2021 Apr 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Drug Resistance, Neoplasm* , Philadelphia Chromosome* , Salvage Therapy*, Graft vs Host Disease/*therapy , Hematopoietic Stem Cell Transplantation/*methods , Immunotherapy, Adoptive/*adverse effects , Neoplasm Recurrence, Local/*therapy , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/*therapy, Adolescent ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Graft vs Host Disease/etiology ; Graft vs Host Disease/pathology ; Humans ; Infant ; Male ; Neoplasm Recurrence, Local/pathology ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Prognosis ; Retrospective Studies ; Survival Rate ; Transplantation, Haploidentical

المؤلفون: Bian L; Department of Breast Oncology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100070, China., Xu BH; Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China., Di LJ; Peking University Cancer Hospital & Institute, Beijing 100038, China., Wang T; Department of Breast Oncology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100070, China., Wang XJ; Zhejiang Cancer Hospital, Hangzhou310000, China., Jiao SC; The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China., Yang JL; The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China., Tong ZS; Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China., Liu J; Fujian Cancer Hospital, Fuzhou 350011, China., Feng JF; Jiangsu Cancer Hospital, Nanjing 210009, China., Liu DG; Sun Yat-sen University Cancer Center, Guangzhou 510080, China., Yu QT; Guangxi Medical University Affiliated Cancer Hospital, Nanning 530021, China., Liu YP; The First Hospital of China Medical University, Shenyang110001, China., Ma Y; Sunshine Guojian Pharmaceutical(Shanghai)Co., Ltd, Shanghai 200090, China., Yu H; Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 210002 China., Jiang ZF; Department of Breast Oncology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100070, China.

المصدر: Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2020 Aug 11; Vol. 100 (30), pp. 2351-2357.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 7511141 Publication Model: Print Cited Medium: Print ISSN: 0376-2491 (Print) Linking ISSN: 03762491 NLM ISO Abbreviation: Zhonghua Yi Xue Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: Vinorelbine*/therapeutic use, Antibodies, Monoclonal, Humanized/*therapeutic use , Breast Neoplasms/*drug therapy, Antineoplastic Combined Chemotherapy Protocols ; China ; Humans ; Neoplasm Metastasis ; Prospective Studies ; Receptor, ErbB-2 ; Stroke Volume ; Trastuzumab/therapeutic use ; Treatment Outcome ; Ventricular Function, Left ; Vinblastine/therapeutic use